期刊文献+

TRAIL在重型肝炎患者PBMC和血清中的表达及血浆置换治疗前后的变化 被引量:9

Changes in levels of TRAIL mRNA in PBMCs and sTRAIL in serum in patients with severe hepatitis between before and after plasma exchange therapy
暂未订购
导出
摘要 目的:探讨肿瘤坏死因子相关凋亡诱导配体(TRAIL)在重型肝炎发病机制中的作用以及血浆置换治疗前后变化的意义.方法:采用实时荧光定量PCR反应检测30例重型肝炎患者外周血单个核细胞(PBMC)TRAILmRNA的水平,采用ELISA法检测其血清可溶性TRAIL(sTRAIL)的水平,并与肝功能相关指标进行相关性分析.观察血浆置换(PE)治疗前后TRAIL的变化,比较治疗有效组和治疗无效组之间TRAIL水平差异.结果:重型肝炎患者PBMCTRAILmRNA的水平及血清sTRAIL的水平均明显高于健康对照组(0.0622±0.0227vs0.0059±0.0023,P<0.05;9.1058±3.2260vs2.4552±1.7485,P<0.01).mTRAIL和sTRAIL与肝功能相关指标总胆红素(TB)、白蛋白(ALB)以及凝血酶原时间(PT)均无直线相关性,膜型TRAIL(mTRAIL)和sTRAIL之间也无直线相关性.PE治疗后,肝功能相关指标改善;PBMCTRAILmRNA水平下降,治疗前后有显著性差异(0.0622±0.0227vs0.0214±0.0140,P<0.001);而血清sTRAIL水平在PE治疗前后无明显变化.治疗有效组PBMCTRAILmRNA水平、血清sTRAIL水平均低于治疗无效组,差异显著(0.0154±0.0076vs0.0320±0.0178,P<0.01;8.0476±3.5599vs11.0479±2.6694,P<0.05).结论:TRAIL介导的细胞凋亡在重型肝炎病理损害过程中起着重要的作用,TRAIL的水平在一定程度上能反映患者的肝脏损伤程度.从近期观察,PE治疗能降低患者PBMCTRAILmRNA水平,但不能降低血清sTRAIL水平. AIM:To investigate the role of TNF-related apoptosis-inducing ligand(TRAIL)in the pathogenesis of severe hepatitis and to detect the impact of plasma exchange therapy on the levels of TRAIL. METHODS:The expression of membrane-bound TRAIL in peripheral blood mononuclear cells(PBMCs)was examined by real-time fluorescence quantitative PCR,while serum levels of soluble TRAIL(sTRAIL)were measured by ELI-SA.Correlation analysis was performed among serum TBIL,ALB and PT.Furthermore,the levels of TRAIL in patients after plasma exchange (PE)therapy were determined. RESULTS:The levels of TRAIL mRNA in PBMCs and sTRAIL in serum were significantly higher in patients with severe hepatitis than in normal controls(P0.05,0.01).The levels of TRAIL mRNA in PBMCs and sTRAIL in serum had no significant association with serum TBIL, ALB and PT,and the levels of TRAIL mRNA in PBMCs had no significant association with serum sTRAIL.The levels of TRAIL in PBMCs were significantly lower in patients with severe hepatitis after PE therapy than before PE therapy (P0.001),while serum sTRAIL levels showed no significant changes between before and after therapy.The levels of TRAIL mRNA in PBMCs and sTRAIL in serum were significantly lower in patients with a positive treatment response than in those with a negative treatment response(P 0.01,0.05). CONCLUSION:TRAIL-mediated apoptosis probably plays a key role in the pathogenesis of severe hepatitis.TRAIL level can be used as a marker for evaluation of the degree of liver damage in patients with severe hepatitis.
出处 《世界华人消化杂志》 CAS 北大核心 2011年第19期2063-2067,共5页 World Chinese Journal of Digestology
关键词 肿瘤坏死因子相关凋亡诱导配体 外周血单个核细胞 重型肝炎 血浆置换 Tumor necrosis factor-related apoptosis-inducing ligand Peripheral blood mononuclear cells Severe hepatitis Plasma exchange
  • 相关文献

参考文献7

二级参考文献36

  • 1宋蕊,王玉梅,石理兰,冯国和,马力,窦晓光.HBV慢性感染患者PBMC凋亡与血清病毒载量[J].世界华人消化杂志,2004,12(7):1574-1577. 被引量:5
  • 2刘征波,范学工,胡国龄.TRAIL及TRAIL受体在慢性乙型肝炎患者外周血淋巴细胞的表达[J].中华微生物学和免疫学杂志,2004,24(11):897-900. 被引量:6
  • 3郭皓宇,谭德明,徐旭雯.慢性乙型肝炎患者外周血单个核细胞中HBV cccDNA预测拉米夫定的治疗效果[J].世界华人消化杂志,2005,13(10):1202-1205. 被引量:14
  • 4[1]Wiley SR,Schooley K,Smolak PJ,Din WS,Huang CP,Nicholl JK,Sutherland GR,Smith TD,Rauch C,Smith CA.Identification and characterization of a new member of the TNF family that induces apoptosis.Immunity 1995; 3:673-682
  • 5[2]Kayagaki N,Yamaguchi N,Nakayama M,Kawasaki A,Akiba H,Okumura K,Yagita H.Involvement of TNF-related apoptosis-inducing ligand in human CD4+ T cell-mediated cytotoxicity.J Immunol 1999; 162:2639-2647
  • 6[3]Chinese Society of Infectious Disease and Parasitology,Chinese Society of Hepatology,Chinese Medical Association.The programme of prevention and treatment for viral hepatitis.Zhonghua Ganzangbing Zazhi 2000; 8:324-329
  • 7[4]Yoon JH,Gores GJ.Death receptor-mediated apoptosis and the liver.J Hepatol 2002; 37:400-410
  • 8[5]Mochizuki K,Hayashi N,Hiramatsu N,Katayama K,Kawanishi Y,Kasahara A,Fusamoto H,Kamada T.Fas antigen expression in liver tissues of patients with chronic hepatitis B.J Hepatol 1996; 24:1-7
  • 9[6]Marinos G,Naoumov NV,Rossol S,Torre F,Wong PY,Gallati H,Portmann B,Williams R.Tumor necrosis factor receptors in patients with chronic hepatitis B virus infection.Gastroenterol 1995; 108:1453-1463
  • 10[7]Walczak H,Miller RE,Ariail K,Gliniak B,Griffith TS,Kubin M,Chin W,Jones J,Woodward A,Le T,Smith C,Smolak P,Goodwin RG,Rauch CT,Schuh JC,Lynch DH.Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.Nat Med 1999; 5:157-163

共引文献14095

同被引文献88

引证文献9

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部